1. Home
  2. MIAX vs TMDX Comparison

MIAX vs TMDX Comparison

Compare MIAX & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MIAX

Miami International Holdings Inc.

N/A

Current Price

$43.99

Market Cap

3.8B

Sector

Finance

ML Signal

N/A

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$122.54

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIAX
TMDX
Founded
2007
1998
Country
United States
United States
Employees
N/A
728
Industry
Investment Bankers/Brokers/Service
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.2B
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
MIAX
TMDX
Price
$43.99
$122.54
Analyst Decision
Buy
Buy
Analyst Count
6
8
Target Price
$47.20
$144.25
AVG Volume (30 Days)
1.2M
664.3K
Earning Date
02-22-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
170.70
EPS
N/A
2.54
Revenue
$1,318,535,000.00
$566,354,000.00
Revenue This Year
N/A
$38.81
Revenue Next Year
$19.04
$20.49
P/E Ratio
N/A
$47.97
Revenue Growth
22.86
41.20
52 Week Low
$28.63
$55.00
52 Week High
$51.38
$156.00

Technical Indicators

Market Signals
Indicator
MIAX
TMDX
Relative Strength Index (RSI) N/A 42.70
Support Level N/A $121.00
Resistance Level N/A $133.29
Average True Range (ATR) 0.00 4.77
MACD 0.00 -0.83
Stochastic Oscillator 0.00 22.79

Price Performance

Historical Comparison
MIAX
TMDX

About MIAX Miami International Holdings Inc.

Miami International Holdings Inc is a technology-driven leader in building and operating regulated financial marketplaces across multiple asset classes and geographies. Its MIAX Exchange marketplaces are enabled by its in-house built, proprietary technology. It maintains a broad portfolio of U.S. exchange and clearing licenses, in both securities and futures. The company operates markets across a diverse number of asset classes including options and cash equities as well as futures and options on futures.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: